Compare TMUS & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMUS | NVO |
|---|---|---|
| Founded | 1994 | 1923 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.2B | 269.6B |
| IPO Year | 2004 | N/A |
| Metric | TMUS | NVO |
|---|---|---|
| Price | $221.48 | $38.55 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 11 |
| Target Price | ★ $258.00 | $51.00 |
| AVG Volume (30 Days) | 5.7M | ★ 21.6M |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | 1.85% | ★ 3.15% |
| EPS Growth | ★ 0.62 | N/A |
| EPS | ★ 9.72 | N/A |
| Revenue | ★ $40,604,000,000.00 | N/A |
| Revenue This Year | $9.29 | N/A |
| Revenue Next Year | $4.58 | $4.39 |
| P/E Ratio | $22.70 | ★ $13.60 |
| Revenue Growth | ★ 9.03 | N/A |
| 52 Week Low | $181.36 | $35.85 |
| 52 Week High | $272.60 | $82.23 |
| Indicator | TMUS | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 65.30 | 31.52 |
| Support Level | $212.66 | N/A |
| Resistance Level | $224.75 | $50.30 |
| Average True Range (ATR) | 4.99 | 0.89 |
| MACD | 0.03 | -0.21 |
| Stochastic Oscillator | 73.33 | 19.46 |
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 86 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 8 million residential and business customers with its wireless network. It also serves 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.